PortfoliosLab logoPortfoliosLab logo
FTXH vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FTXH vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FTXH achieves a 7.62% return, which is significantly lower than IHE's 9.33% return.


FTXH

1D
2.50%
1M
3.66%
YTD
7.62%
6M
9.20%
1Y
39.54%
3Y*
12.33%
5Y*
8.33%
10Y*

IHE

1D
2.69%
1M
3.48%
YTD
9.33%
6M
12.42%
1Y
43.59%
3Y*
18.33%
5Y*
10.57%
10Y*
7.97%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FTXH vs. IHE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FTXH
First Trust Nasdaq Pharmaceuticals ETF
7.62%24.15%2.98%-1.41%2.55%6.14%11.73%22.13%-9.51%19.44%
IHE
iShares U.S. Pharmaceuticals ETF
9.33%31.69%8.13%1.06%-4.87%13.07%13.66%15.47%-7.76%10.64%

Correlation

The correlation between FTXH and IHE is 0.88, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.88

Correlation (3Y)
Calculated over the trailing 3-year period

0.86

Correlation (5Y)
Calculated over the trailing 5-year period

0.85

Correlation (All Time)
Calculated using the full available price history since Sep 23, 2016

0.76

The correlation between FTXH and IHE shifts across timeframes, from 0.76 (all time) to 0.88 (1 year), reflecting how their relationship changes across market environments.

FTXH vs. IHE - Sectors Allocation Comparison


Sectors
FTXH
IHE

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

FTXH
100.0%
IHE
100.0%

Basic Materials

FTXH

-

IHE

-

Communication Services

FTXH

-

IHE

-

Consumer Cyclical

FTXH

-

IHE

-

Consumer Defensive

FTXH

-

IHE

-

Energy

FTXH

-

IHE

-

Financial Services

FTXH

-

IHE

-

Industrials

FTXH

-

IHE

-

Real Estate

FTXH

-

IHE

-

Technology

FTXH

-

IHE

-

Utilities

FTXH

-

IHE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTXH vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH
FTXH Risk / Return Rank: 7777
Overall Rank
FTXH Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 7777
Sortino Ratio Rank
FTXH Omega Ratio Rank: 6767
Omega Ratio Rank
FTXH Calmar Ratio Rank: 8989
Calmar Ratio Rank
FTXH Martin Ratio Rank: 8080
Martin Ratio Rank

IHE
IHE Risk / Return Rank: 8181
Overall Rank
IHE Sharpe Ratio Rank: 7979
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 8383
Sortino Ratio Rank
IHE Omega Ratio Rank: 7373
Omega Ratio Rank
IHE Calmar Ratio Rank: 8888
Calmar Ratio Rank
IHE Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTXH vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FTXHIHEDifference
Sharpe ratioReturn per unit of total volatility

-0.22

Sortino ratioReturn per unit of downside risk

-0.27

Omega ratioGain probability vs. loss probability

1.39

1.43

-0.04

Calmar ratioReturn relative to maximum drawdown

5.32

5.17

+0.15

Martin ratioReturn relative to average drawdown

15.35

15.58

-0.23

FTXH vs. IHE - Sharpe Ratio Comparison

The current FTXH Sharpe Ratio is 2.32, which is comparable to the IHE Sharpe Ratio of 2.54. The chart below compares the historical Sharpe Ratios of FTXH and IHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


FTXHIHEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.32

2.54

-0.22

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.51

0.65

-0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

0.39

0.51

-0.12

Drawdowns

FTXH vs. IHE - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for FTXH and IHE.


Loading charts...

Drawdown Indicators


FTXHIHEDifference

Max Drawdown

Largest peak-to-trough decline

-32.11%

-38.20%

+6.09%

Max Drawdown (1Y)

Largest decline over 1 year

-7.47%

-8.47%

+1.00%

Max Drawdown (3Y)

Largest decline over 3 years

-19.51%

-15.92%

-3.59%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

-16.03%

-3.48%

Max Drawdown (10Y)

Largest decline over 10 years

-29.59%

Current Drawdown

Current decline from peak

-0.45%

-0.18%

-0.27%

Average Drawdown

Average peak-to-trough decline

-5.84%

-7.92%

+2.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.58%

2.81%

-0.23%

Volatility

FTXH vs. IHE - Volatility Comparison

The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.38%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 6.04%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FTXHIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.38%

6.04%

-0.66%

Volatility (6M)

Calculated over the trailing 6-month period

11.96%

12.70%

-0.74%

Volatility (1Y)

Calculated over the trailing 1-year period

17.14%

17.26%

-0.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.34%

16.28%

+0.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.43%

18.07%

+0.36%

FTXH vs. IHE - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than IHE's 0.42% expense ratio.


Dividends

FTXH vs. IHE - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.19%, less than IHE's 1.61% yield.


PositionTTM20252024202320222021202020192018201720162015
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.19%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%0.00%
IHE
iShares U.S. Pharmaceuticals ETF
1.61%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions


FTXH and IHE have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IHE has higher volatility (6.04%) compared to FTXH (5.38%). In terms of maximum drawdown, FTXH dropped -32.11% vs IHE's -38.20%.

On 5-year performance, IHE leads with 10.57% vs 8.33% for FTXH. On fees, IHE is cheaper at 0.42% per year. On volatility, FTXH has been the lower-risk option at 5.38%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, IHE has performed better with a 10.57% return vs 8.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IHE is cheaper with a 0.42% expense ratio, compared with 0.60% for FTXH.

IHE has the higher dividend yield at 1.61%, compared with 1.19% for FTXH.

FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.60% for FTXH and 0.42% for IHE.

IHE currently has the higher Sharpe Ratio (2.54 vs 2.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FTXH and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer